Advanced Biomed Inc., a Nevada-based company, has announced a new shareholder agreement with Helena Global Investment Opportunities I Ltd. The agreement, dated June 6, 2025, grants Advanced Biomed the right to issue and sell up to $25 million of its common stock to Helena Global. The common stock will be traded under the symbol "ADVB" on the Nasdaq Capital Markets. This strategic move is expected to bolster Advanced Biomed's financial position and support its ongoing growth initiatives. Helena Global, represented by Managing Partner Jeremy Weech, will play a significant role as an investor in this collaboration.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Advanced Biomed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-052234), on June 06, 2025, and is solely responsible for the information contained therein.